Sino Medical Sciences Technology Inc is a China-based company mainly engaged in the research, development, production and sales of high-end interventional medical devices. The Company's product pipeline covers the field of interventional therapy such as cardiovascular, cerebrovascular, and structural heart disease. The Company's main products include coronary drug stent system and balloon dilatation catheters. The Company manufactures and sells products covering two main categories: coronary intervention and neurointervention, including coronary stents, coronary balloons, neurostents, neuroballoons, and related products. These products are primarily used in interventional medical treatments such as coronary artery stenting. The Company conducts its business within the domestic market and overseas markets.